Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation
- Conditions
- Tobacco Use Disorder
- Registration Number
- NCT05766553
- Lead Sponsor
- Centre Hospitalier Henri Laborit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria:<br><br> - Any patient consuming 10 to 40 cigarettes per day<br><br> - Woman or man aged 18 to 75 inclusive<br><br> - Substance use disorder according to the DSM5 classification<br><br> - Benefit from social security or benefit from it through a third party in accordance<br> with French law on research involving the human person<br><br> - Having signed the informed consent form after having received written information.<br><br>Exclusion Criteria:<br><br> - Disabling cognitive disorders<br><br> - Patient under 18 or over 75 years old.<br><br> - Patient with a psychological disorder or a psychiatric pathology requiring<br> specialized follow-up<br><br> - Patient with addiction to another product.<br><br> - Cardiological pathologies that could compromise the participation of patients,<br> detected by an ECG (only for patients who will be randomized in the experimental<br> group).<br><br> - Advanced pulmonary, renal, and hepatic diseases, or any unstable and serious medical<br> conditions that could compromise the patient's participation in the study, subject<br> to the judgment of the doctor<br><br> - Pregnant or breastfeeding woman<br><br> - Simultaneous participation in another trial<br><br> - Employee of the investigator or of the clinical trial site<br><br> - Patients protected by law<br><br> - Patients who do not speak the French language<br><br> - People not covered by state health insurance<br><br> - Patients who in the opinion of the investigator are unable to complete the<br> questionnaires<br><br> - Patient claustrophobic or anxious about using the cabin<br><br> - Patient allergic to a molecule present in nicotine substitutes
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse at 3 months;Relapse at 6 months
- Secondary Outcome Measures
Name Time Method